Skip to main content
logo
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.95
-0.05 (-0.14%)
At close: Sep 17, 2026

BIONET Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,4473,9343,252--
Market Cap Growth
-37.81%20.99%---
Enterprise Value
1,4392,8012,381--
Last Close Price
34.9556.2046.45--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
12.4425.4739.99--
PB Ratio
2.053.242.51--
P/TBV Ratio
2.063.242.51--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
7.3218.1329.28--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.01---
Net Debt / Equity Ratio
-0.84-0.86-0.94-0.99-1.11
Net Debt / EBITDA Ratio
11.939.9512.6413.56-
Net Debt / FCF Ratio
11.107.577.1111.3415.53
Asset Turnover
0.150.120.090.02-
Inventory Turnover
2.653.125.31--
Quick Ratio
15.9818.9723.0243.609.95
Current Ratio
16.7519.7023.7443.719.98
Return on Equity (ROE)
-6.87%-7.76%-9.46%-12.95%-
Return on Assets (ROA)
-4.98%-5.53%-6.57%-8.26%-
Return on Capital Employed (ROCE)
-8.50%-9.50%-7.70%-7.40%-25.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-3.44%-2.48%-2.65%--
FCF Yield
-3.71%-3.52%-5.26%--
Buyback Yield / Dilution
-3.69%-21.88%-280.50%-1278.45%-